Related Experiment Video
Updated: Mar 13, 2026

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
Published on: September 4, 2019
RNAi screens identify CHD4 as an essential gene in breast cancer growth
Carolina D'Alesio1, Simona Punzi1, Angelo Cicalese1
1Department of Experimental Oncology, European Institute of Oncology, Milan 20141, Italy.
Abstract:
Epigenetic regulation plays an essential role in tumor development and epigenetic modifiers are considered optimal potential druggable candidates. In order to identify new breast cancer vulnerabilities and improve therapeutic chances for patients, we performed in vivo and in vitro shRNA screens in a human breast cancer cell model (MCF10DCIS.com cell line) using epigenetic libraries. Among the genes identified in our screening, we deeply investigated the role of Chromodomain Helicase DNA binding Protein 4 (CHD4) in breast cancer tumorigenesis. CHD4 silencing significantly reduced tumor growth in vivo and proliferation in vitro of MCF10DCIS.com cells. Similarly, in vivo breast cancer growth was decreased in a spontaneous mouse model of breast carcinoma (MMTV-NeuT system) and in metastatic patient-derived xenograft models. Conversely, no reduction in proliferative ability of non-transformed mammary epithelial cells (MCF10A) was detected. Moreover, we showed that CHD4 depletion arrests proliferation by inducing a G0/G1 block of cell cycle associated with up-regulation of CDKN1A (p21). These results highlight the relevance of genetic screens in the identification of tumor frailties and the role of CHD4 as a potential pharmacological target to inhibit breast cancer growth.
Insights
Genetic screens identified Chromodomain Helicase DNA binding Protein 4 (CHD4) as a key driver of breast cancer growth. Silencing CHD4 inhibited tumor proliferation and progression, suggesting it as a potential therapeutic target for breast cancer.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic regulation is crucial in tumor development.
- Epigenetic modifiers are promising drug targets for cancer therapy.
- Identifying novel breast cancer vulnerabilities can improve patient outcomes.
Purpose of the Study:
- To identify new therapeutic targets for breast cancer by screening epigenetic modifiers.
- To investigate the role of Chromodomain Helicase DNA binding Protein 4 (CHD4) in breast cancer tumorigenesis.
Main Methods:
- Conducted in vivo and in vitro shRNA screens using epigenetic libraries in a human breast cancer cell model (MCF10DCIS.com).
- Investigated the function of CHD4 in breast cancer using various in vivo models, including spontaneous mouse models (MMTV-NeuT) and patient-derived xenografts.
- Analyzed cell cycle progression and gene expression changes upon CHD4 depletion.
Main Results:
- CHD4 silencing significantly reduced tumor growth in vivo and proliferation in vitro in breast cancer models.
- CHD4 depletion did not affect the proliferation of non-transformed mammary epithelial cells (MCF10A).
- CHD4 depletion induced a G0/G1 cell cycle arrest, associated with increased CDKN1A (p21) expression.
Conclusions:
- Genetic screens are effective in identifying tumor vulnerabilities.
- CHD4 plays a critical role in breast cancer progression.
- CHD4 inhibition represents a potential therapeutic strategy for breast cancer treatment.
Related Concept Videos
Experimental RNAi
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Hedgehog Signaling Pathway
lncRNA - Long Non-coding RNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

